Rumeurs, idées reçues, clichés, superstitions, légende : qui dit vrai ? qui dit faux ?
Malaria: Vaccination Launches in Cameroon on January 22

Malaria: Vaccination Launches in Cameroon on January 22

Paru le lundi, 15 janvier 2024 14:57

Cameroon’s Ministry of Public Health (Minsanté) announced on January 8 that a new malaria vaccination campaign will commence on January 22. The campaign primarily targets children born between July 1, 2023, and December 31, 2023, for the first dose, with subsequent doses following the current vaccination calendar. An estimated 249,133 infants are expected to be vaccinated in the first year.

The vaccine, RTS, S (commercially known as Mosquirix), developed by British pharmaceutical giant GSK and supported by Gavi, the Vaccine Alliance, will be administered in a four-dose schedule at 6, 7, 9, and 24 months. The campaign will cover 42 health districts, selected by the Expanded Program on Immunization (EPI) and the National Malaria Control Program (PNLP) due to their high morbidity and mortality rates. In the Centre region, initial vaccinations will take place in the Soa and Mfou (Mefou-et Afamba) health districts, as well as in Yoko, in the Mbam-et-Kim department.

Cameroon received its first shipment of 331,200 doses of the malaria vaccine on December 21, as part of the country’s efforts to control the disease. The country is set to receive a total of nearly 1.3 million doses.

Malaria is endemic in Cameroon, posing a significant risk of illness and death, particularly among children aged 0-59 months. In 2022, the disease accounted for 29.6% of all health facility consultations, with over 3.3 million cases and 2,481 deaths reported, primarily among children under 5, according to PNLP data. Minister Manaouda Malachie stated that the vaccine will bolster the fight against malaria and reduce disease-related morbidity and mortality.


● Fact Cheking



Please publish modules in offcanvas position.